Wesat2001
-
Upload
mohamed-rafique -
Category
Health & Medicine
-
view
168 -
download
0
Transcript of Wesat2001
1
Scaling-Up HIV Treatment Experience from Cameroon in Operational
Research: Main outcomes Sinata Koulla-Shiro MD
Chief, Division Of Operations Research, Cameroon,Vice Chair, National AIDS Control Committee and Infectious
Disease Service,Yaoundé Central Hospital
XVII International AIDS Conference3-8 August 2008, Mexico City
2
OUTLINE
1. Background
2. The Public Health Approach to Scaling –Up
3. Cameroon Model of scaling-up ARV drug access
4. Operations Research and scaling-up programme • Characterisics• Main Outcomes• Key challenges
3
Background (1/2)
2001: 1st UN General Assembly Special Session on HIV/AIDS(UNGASS):Targets and member states committment
2004- 2005: Political Committment accompanied by flow of financial ressources(Domestic, multilateral, Bilateral and Private)
2006: UNGASS: Countries agreed toward Universal Access to Comprehensive Prevention, Care and Support by 2010
4
Background (2/2)
2007: Better tools led to Readjustment of figures by UNAIDS and WHO
33 million people live with HIV at global level 2.7 million people newly infected in 2007
9.7 million need treatment in low and middle income countries end 2007 (WHO,UNAIDS,UNICEFprogress report)
Unprecedented Momentum of Antiretroviral Treatment in Africa
3 million received ART and >2 million in sub-saharan Africa
Access equal or higher among women
Adherence equal or greater than un Europe and North America
5
Number of people receiving antiretroviral therapy in low- and middle-income countries, 2002–2007
6
Antiretroviral therapy coverage in sub-Saharan Africa, 2003–2007
7
Women as a percentage of all people receiving antiretroviral therapy versus women as a percentage of all people needing treatment, selected low- and middle-income countries, 2007a
10% 40% 50% 60%
8
The public health approach to scaling up antiretroviral therapy
9
Cameroon Approach to Scaling –Up HIV Drug Access 2001-2002 ART Programme mainly at Central and Regional
levels
2003:Standardized guidelines for ART in place 2004:Decentralization to District Hospitals catalysed by WHO
« 3by5 » Initiative Strenghthening Health sysytem (procurement, laboratory, task
shifting, M/E tools) Subsidies allocated to initial and follow up lab tests
2005:Mentorship Strategy: Tertiary/2ndry hospitals mentor Primary District Hospitals Training and supervision Referral for laboratory tests Referal for complex cases Process accompanied by Operational Research(ANRS)
10
Reduction in ARV prices in Cameroon between 2001 and 2007
600 000
300 000
70 00022 000 5 000 0
Before CENAME Nov 2000 to21/03/ 2001
1st drop22/03/2001
2nd drop1/08/2002
3rd drop1/10/2004
4th drop1/05/2007
Source: NACC Progress Report
11
National Coverage of Antiretroviral Treatment Sites in Cameroon, 2005
Source: NACC
12
5
12
4
4
7
546
5
5
Accredited Treatment centres (ATC) Mentors per province
Management Units(MU)
Number of MU mentored
National Coverage of ART Management Units and Mentors, 2006
13
Figure 6 : Evolution du nombre des malades sous ARV au Cameroun: juillet 2005 à décembre 2007
10 000
15 000
20 000
25 000
30 000
35 000
40 000
45 000
50 000
juil o5 sept o5 déc o5 mars o6 juin o6 sept o6 déc o6 mars 07 juin 07 sept- 07 déc - 07
Source: NACC, 2008
14
File active des Enfants ( < 15 ans) sous ARV
1 700
1 536
310
643
674
8761 001
1 014 1 183
1 360
300
500
700
900
1 100
1 300
1 500
1 700
1 900
juil o5 déc o5 mai o6 août o6 sept o6 déc o6 mars o7 juin-07 sept-07 déc-07
15
First line ARV drug regimens used for adults in Cameroon, 2007-2008
61,9
10,914,2
11,56
0,15 1,29
0
10
20
30
40
50
60
70
D4t+3TC+NVP AZT+3TC+NVP D4t+3TC+EFV AZT+3TC+EFV TDF Bases
Regimens
Other
ARV Regimens
%Adult First Line ARV Regimens used in Cameroon, 2008
Source: NACC Progress Report, April 2008
16
First line ARV drug regimens used for children in Cameroon, 2007-2008
35,831,9
11,6 11,2 9,5
0
5
10
15
20
25
30
35
40
D4t+3TC+NVP AZT+3TC+NVP D4t+3TC+EFV AZT+3TC+EFV Other
ARV Regimens
%
Source: NACC Progress Report, April 2008
First Line ARV Regimens used for Children in Cameroon, 2008
17
18
19
Components of Scaling-Up Operations Research 4 Complementary Projects
ANRS 12110 trial Stratall,Charles Kouanfack
ANRS 12120: Problematic of Access to Treatment: Advances, Limits and perspectives of decentralization, F. Eboko
ANRS 12108: Scaling –Up and Procurement of Drugs and Biological Tools, B. Coriat/M.J Essi (Presented yesteday)
ANRS 12116: Impact of Access to HIV Management and living conditions of Patients, J. P Moatti/SC Abega
20
The Eval ANRS 12116 Study
Primary Objective: Evaluate the quality of care of patients on ART
About 3000 patients; 26 Health care Facilities;Urban and rural Variables studied Medical Effeciency: Sociobehavioral Factors
Adherence to treatment Health Related Quality of life Sociodemograhic and economic factors
Cost effectiveness Equity Impact on risky behaviour: Impact on Health System KAP
21
Outcome of decentralization
Early outcomes better at district level : Early access to treatment HIV service performance HRQL especially mental Adherence to therapy Task shifting Positive role of associations of PLWH
Patients perception in favour of decentralization
Financial accessibility of HIV services remains a major barrier
Other Challenges of ART scale-Up ARV drug stocks out unsafe sex common among PLWH on ART and erronous beliefs that ART
efficacy prevents HIV transmission is a major determinant Unfelt impact of Community relay workers: need revisiting Health workers dissatisfied with working conditions Sustained efforts on HIV Prevention
22
Impact of 3 scenarios on HIV infection in sub-saharan Africa, 2003-2020